Nonparametric Bayesian estimation from interval-censored data using Monte Carlo methods

Journal of Statistical Planning and Inference

Volumn 98, Issue 1-2, 2001, Pages 73-87

  Calle, M Luz ^a   Gómez, Guadalupe ^b  

^a UNIVERSITY OF VIC CENTRAL UNIVERSITY OF CATALONIA   (Spain)

^b UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

Author keywords

62E25; 62F15; 62G99; Bayesian analysis; Gibbs sampler; Interval censoring; Markov chain Monte Carlo methods; Nonparametric estimation; Survival analysis

Indexed keywords

EID: 0042909099     PISSN: 03783758     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-3758(00)00320-7     Document Type: Article

References (26)

1. Best N.G., Cowles M.K., Vines S.K. CODA Manual version 0.30. 1995;MRC Biostatistics unit, Cambridge, UK.
2. Christensen R., Johnson W. Modelling accelerated failure time with a Dirichlet process. Biometrika. 75:1988;693-704.
3. De Gruttola V., Lagakos S. Analysis of doubly-censored survival data, with application to AIDS. Biometrics. 45:1989;1-11.
4. Doksum K. Tailfree and neutral random probabilities and their posterior distributions. Ann. Probab. 2:1974;183-201.
5. Doss H. Bayesian nonparametric estimation for incomplete data via successive substitution sampling. Ann. Statist. 22:1994;1763-1786.
6. Doss, H., Narasimhan, 1998. Dynamic display of changing posterior in Bayesian survival analysis. In: Dey, D., Müller, P., Sinha, D. (Eds.), Practical Nonparametric and Semiparametric Bayesian Statistics. Springer, New York, pp. 63-87.
7. Ferguson T.S. A Bayesian analysis of some nonparametric problems. Ann. Statist. 1:1973;209-230.
8. Gelfand A.E., Smith F.M. Sampling-based approaches to calculating marginal densities. J. Amer. Statist. Assoc. 85:1990;398-409.
9. Gelman A., Rubin D.B. Inference from iterative simulation using multiple sequences. Statist. Sci. 7:1992;457-472.
10. Gilks W.R., Richardson S., Spiegelhalter D.J. Markov Chain Monte Carlo in Practice. 1996;Chapman & Hall, London.
11. Gómez G., Calle M.L. Nonparametric estimation with doubly-censored data. J. Appl. Statist. 26(1):1999;45-58.
12. Gómez G., Lagakos S.W. Estimation of the infection time and latency distribution of AIDS with doubly censored data. Biometrics. 50:1994;204-212.
13. Johnson W., Christensen R. Bayesian nonparametric survival analysis for grouped data. Can. J. Statist. 14:1986;307-314.
14. Joly P., Commenges D., Letenneur L. A penalized likelihood approach for arbitrarily censored and truncated data: application to age-specific incidence of dementia. Biometrics. 54:1998;185-194.
15. Leung K.M., Elashoff R.M., Afifi A.A. Censoring issues in survival analysis. Annu. Rev. Publ. Health. 18:1997;83-104.
16. Lindley D.V., Smith A.F.M. Bayes estimates for the linear model (with discussion). J. Roy. Statist. Soc. Ser. B. 34:1972;1-41.
17. Newton M.A., Zhang Y. A recursive algorithm for nonparametric analysis with missing data. Biometrika. 86:1999;15-26.
18. Peto R. Experimental survival curves for interval-censored data. J. Roy. Statist. Soc. Ser. C. 22:1973;86-91.
19. Rai K., Susarla V., Van Ryzin J. Shrinkage estimation in nonparametric Bayesian survival analysis: a simulation study. Comm. Statist.-Simulation Comput. 3:1980;271-298.
20. Sinha D., Dey D.K. Semiparametric Bayesian analysis of survival data. J. Amer. Statist. Assoc. 92:1997;1195-1212.
21. Smith P.J., Thompson T.J., Jereb J.A. A model for interval-censored tuberculosis outbreak data. Statist. Med. 16:1997;485-496.
22. Smith A.F.M., Roberts G.O. Bayesian computation via the Gibbs sampler and related Markov chain Monte Carlo methods. J. Roy. Statist. Soc. Ser. B. 55:1993;3-23.
23. Susarla V., Van Ryzin J. Nonparametric Bayesian estimation of survival curves from incomplete observations. J. Amer. Statist. Assoc. 71:1976;897-902.
24. Susarla V., Van Ryzin J. Large sample theory for a Bayesian nonparametric survival curve estimator based on censored samples. Ann. Statist. 6:1978;755-768.
25. Turnbull B.W. The empirical distribution function with arbitrarily grouped, censored and truncated data. J. Roy. Statist. Soc. Ser. B. 38:1976;290-295.
26. Volberding P.A., Lagakos S.W., Grimes J.M., Stein D.S., Rooney J., Meng T-C., Fischl M.A., Collier A.C., Phair J.P., Hirsch M.D., Hardy W.D., Balfour H.H., Reichman R.C. A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. New England J. Med. 333:1995;401-451.